Correlation Between Axsome Therapeutics and Immunic
Can any of the company-specific risk be diversified away by investing in both Axsome Therapeutics and Immunic at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Axsome Therapeutics and Immunic into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Axsome Therapeutics and Immunic, you can compare the effects of market volatilities on Axsome Therapeutics and Immunic and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Axsome Therapeutics with a short position of Immunic. Check out your portfolio center. Please also check ongoing floating volatility patterns of Axsome Therapeutics and Immunic.
Diversification Opportunities for Axsome Therapeutics and Immunic
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Axsome and Immunic is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Axsome Therapeutics and Immunic in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunic and Axsome Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Axsome Therapeutics are associated (or correlated) with Immunic. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunic has no effect on the direction of Axsome Therapeutics i.e., Axsome Therapeutics and Immunic go up and down completely randomly.
Pair Corralation between Axsome Therapeutics and Immunic
Given the investment horizon of 90 days Axsome Therapeutics is expected to generate 1.51 times less return on investment than Immunic. But when comparing it to its historical volatility, Axsome Therapeutics is 1.88 times less risky than Immunic. It trades about 0.03 of its potential returns per unit of risk. Immunic is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 119.00 in Immunic on August 29, 2024 and sell it today you would earn a total of 1.00 from holding Immunic or generate 0.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Axsome Therapeutics vs. Immunic
Performance |
| Timeline |
| Axsome Therapeutics |
| Immunic |
Axsome Therapeutics and Immunic Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Axsome Therapeutics and Immunic
The main advantage of trading using opposite Axsome Therapeutics and Immunic positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Axsome Therapeutics position performs unexpectedly, Immunic can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunic will offset losses from the drop in Immunic's long position.| Axsome Therapeutics vs. Incyte | Axsome Therapeutics vs. Sarepta Therapeutics | Axsome Therapeutics vs. ACADIA Pharmaceuticals | Axsome Therapeutics vs. Viking Therapeutics |
| Immunic vs. Generation Bio Co | Immunic vs. Kronos Bio | Immunic vs. Erasca Inc | Immunic vs. C4 Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |